|
|
|
|
|
|
|
|
|
|
Super Quote | Detail Quote | Interactive Chart | Transaction | Related News | Related Securities | Company Information | Dividend Records | Short Sell
01419 HUMAN HEALTH
Nominal 
0.800 +0.008 (+1.010%) | 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Turnover | 295,190 | -56.671% | 681,274 | 388,544 | 230,664 | 254,805 |
| Cost of Sales | (154,684) | -27.526% | (213,434) | (173,049) | (121,695) | (137,266) |
| Gross Profit | 140,506 | -69.967% | 467,840 | 215,495 | 108,969 | 117,539 |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | ||
| Change in FV & Impairment on Inv. Prop. | -- | -- | -- | -- | -- | -- | |
| Change in FV & Impairment on Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) on Disposal | -- | -- | -- | -- | -- | -- | |
| Other Non-operating Items | -- | -- | -- | -- | -- | -- | |
| Share of Results of Asso. & JCEs | (760) | -35.319% | (1,175) | (388) | 109 | (882) | |
| Profit / (Loss) before Taxation | 23,934 | -92.638% | 325,092 | 108,226 | 18,292 | 3,795 | |
| Taxation | (3,901) | -93.154% | (56,980) | (17,798) | (1,398) | (651) | |
| Profit / (Loss) from Discontinued Operations | -- | -- | -- | -- | -- | -- | |
| Non-controlling Interests | 0 | -- | 0 | 0 | 0 | 0 | |
| Others | -- | -- | -- | -- | -- | -- | |
| Profit / (Loss) Attributable to Shareholders | 20,033 | -92.528% | 268,112 | 90,428 | 16,894 | 3,144 | |
| 2023/12 - Interim HKD(K$) | %Chg (Compare to Interim) | 2022/12 HKD(K$) | 2021/12 HKD(K$) | 2020/12 HKD(K$) | 2019/12 HKD(K$) | |
| Net Finance Costs / (Income) | (4,337) | -- | 1,760 | 1,024 | 1,523 | 1,656 |
| Depreciation & Amortisation | 33,116 | -7.737% | 35,893 | 29,818 | 35,328 | 37,330 |
| Directors' Emoluments | -- | -- | -- | -- | -- | -- |
| 2023/12 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| Auditor's Opinion Status | N/A | -- | N/A | N/A | N/A | N/A |
Market Valuation Indicators
| 2023/12 - Interim | %Chg (Compare to Interim) | 2022/12 | 2021/12 | 2020/12 | 2019/12 | |
| EPS (cts) | 5.300 | -92.493% | 70.600 | 23.800 | 4.500 | 0.800 |
| DPS (cts) | 0.000 | -- | 0.000 | 0.000 | 0.000 | 0.000 |
| Dividend Payout Ratio (%) | -- | -- | -- | -- | -- | -- |
| Cash flow per share ($) | -- | -- | -- | -- | -- | -- |
| NBV per share ($) | 2.014 | -- | 2.360 | 1.200 | 0.730 | 0.804 |
| Remarks: | Real time quote last updated: 04/12/2024 17:59 |
| Real-time basic market prices of Hong Kong securities are provided by HKEx; a Designated Website authorized by the HKEx Group to provide the Service. | |
| Profit / (Loss) Attributable to Shareholders ($) | HKD 24,189,000 |
| %Change | -86.624% |
| EPS / (LPS) | HKD 0.064 |
| NBV Per Share ($) | HKD 2.020 |